Literature DB >> 18784115

PTH mutation with primary hyperparathyroidism and undetectable intact PTH.

Amy Y M Au, Kerrie McDonald, Anthony Gill, Mark Sywak, Terrence Diamond, Arthur D Conigrave, Roderick J Clifton-Bligh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18784115     DOI： 10.1056/NEJMc0802570

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  10 in total

Review 1.  Diseases of the parathyroid gland in chronic kidney disease.

Authors:  Hirotaka Komaba; Takatoshi Kakuta; Masafumi Fukagawa
Journal:  Clin Exp Nephrol       Date:  2011-08-06       Impact factor: 2.801

2.  A Homozygous [Cys25]PTH(1-84) Mutation That Impairs PTH/PTHrP Receptor Activation Defines a Novel Form of Hypoparathyroidism.

Authors:  Sihoon Lee; Michael Mannstadt; Jun Guo; Seul Min Kim; Hyon-Seung Yi; Ashok Khatri; Thomas Dean; Makoto Okazaki; Thomas J Gardella; Harald Jüppner
Journal:  J Bone Miner Res       Date:  2015-06-08       Impact factor: 6.741

3.  Mutational analysis of GCMB, a parathyroid-specific transcription factor, in parathyroid adenoma of primary hyperparathyroidism.

Authors:  Michael Mannstadt; Emily Holick; Wenping Zhao; Harald Jüppner
Journal:  J Endocrinol       Date:  2011-06-03       Impact factor: 4.286

4.  Primary hyperparathyroidism with low intact PTH levels in a 14-year-old girl.

Authors:  Amanda D Benaderet; Amy M Burton; Roderick Clifton-Bligh; Ambika P Ashraf
Journal:  J Clin Endocrinol Metab       Date:  2011-05-18       Impact factor: 5.958

5.  Molecular pathways associated with transcriptional alterations in hyperparathyroidism.

Authors:  Fang Lee; Jie-Jen Lee; Woan-Ching Jan; Chih-Jen Wu; Han-Hsiang Chen; Shih-Ping Cheng
Journal:  Oncol Lett       Date:  2016-05-25       Impact factor: 2.967

6.  Genome-wide association study evaluating single-nucleotide polymorphisms and outcomes in patients with advanced stage serous ovarian or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study.

Authors:  Kathleen N Moore; David Tritchler; Kenneth M Kaufman; Heather Lankes; Michael C J Quinn; Linda Van Le; Andrew Berchuck; Floor J Backes; Krishnansu S Tewari; Roger B Lee; Joshua P Kesterson; Robert M Wenham; Deborah K Armstrong; Thomas C Krivak; Michael A Bookman; Michael J Birrer
Journal:  Gynecol Oncol       Date:  2017-09-19       Impact factor: 5.482

7.  Intraoperative parathyroid hormone (PTH) testing in patients with primary hyperparathyroidism and PTH levels in the normal range.

Authors:  Fabio Medas; Enrico Erdas; Giulia Loi; Francesco Podda; Lucia Barca; Giuseppe Pisano; Pietro Giorgio Calò
Journal:  BMC Surg       Date:  2019-04-24       Impact factor: 2.102

Review 8.  Hypercalcemic Disorders in Children.

Authors:  Victoria J Stokes; Morten F Nielsen; Fadil M Hannan; Rajesh V Thakker
Journal:  J Bone Miner Res       Date:  2017-11-02       Impact factor: 6.741

Review 9.  Diagnosis, management, histology and genetics of sporadic primary hyperparathyroidism: old knowledge with new tricks.

Authors:  Maria Mizamtsidi; Constantinos Nastos; George Mastorakos; Roberto Dina; Ioannis Vassiliou; Maria Gazouli; Fausto Palazzo
Journal:  Endocr Connect       Date:  2018-01-12       Impact factor: 3.335

Review 10.  Rare PTH Gene Mutations Causing Parathyroid Disorders: A Review.

Authors:  Joon Hyop Lee; Munkhtugs Davaatseren; Sihoon Lee
Journal:  Endocrinol Metab (Seoul)       Date:  2020-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.